Regulation of NF-kB by the Akt kinase
Regulation of NF-kB by the Akt kinase
批准号:
7882941
负责人:
Lawrence P. Kane
金额:
$35.5万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2012-08-31
关键词:
AffectBiologicalCellsComplexDataDevelopmentFamilyGene Expression RegulationGenesGenetic TranscriptionMalignant NeoplasmsMapsMediatingMicroarray AnalysisMolecularMutationNF-kappa BPathway interactionsPhosphorylationPhosphotransferasesPrincipal InvestigatorProtein-Serine-Threonine KinasesProteinsProto-OncogenesRegulationRegulator GenesRoleSiteT-Cell ActivationT-LymphocyteUp-Regulationabstractingbasecell growthinhibitor/antagonistmetaplastic cell transformationneoplastic cellprogramstranscription factor
中文摘要
核因子-βB家族转录因子是关键的调节因子
基因转录。现在已知核因子-βB途径的突变有助于细胞
癌症的转化和发展。我一直在研究丝氨酸/苏氨酸的作用
蛋白激酶Akt在细胞活化和核因子?B诱导中的作用有趣的是,Akt也是一种原癌基因,
在癌症中经常被放大或激活。已知AKT有助于激活许多
下游通路,包括核因子-βB。我假设核因子-βB的激活对
Akt对T细胞活化转化的影响在这一点上,核因子-βB在Akt介导的总体作用
转录上调尚不清楚。此外,目前还不清楚Akt是如何对
核因子-β活化。我们最近在后一个问题上取得了一些进展,表明
蛋白CARMA1是Akt介导的T细胞核因子?B诱导所必需的。此外,Akt还可以与
CARMA1并调节其定位,此外还增加Bcl10的磷酸化,这是
在CARMA1的建筑群中被发现。根据我们的初步数据和上述假设,
提出了三个具体目标。(1)为了更好地了解Akt和
CARMA1影响细胞激活,我们将使用各种分子和细胞生物学方法
这将详细揭示这种互动是如何受到监管的。(2)阐明其作用和调控。
Bcl10的磷酸化,我们将定位Bel 10内的可诱导磷酸化的位置,并确定
Akt在其调控中的作用。(3)确定核因子-βB在Akt介导的基因调控中的整体作用
和转化,我们将首先使用微阵列技术和一种强大的核因子-B抑制因子
揭示哪些Akt诱导基因需要核因子?B活性的途径。类似的方法将是
用来确定核因子?B在Akt介导的转化中的作用。完成这些研究
应披露有关两个重要监管机构之间合作的重要信息
与肿瘤细胞生长-Akt和核因子?B.相关性:许多研究表明,
AKT是细胞转化过程中常见的事件。理解Akt在正常和非正常状态下的作用
病理细胞功能因多条下游通路的存在而变得复杂
从Akt向外辐射。这里描述的研究将使我们更好地理解Akt是如何激活的
其中一条途径--转录因子的核因子-?B家族--以及该途径在Akt介导中的作用
基因上调和细胞转化。这样的知识可能最终会导致更多
Akt异常肿瘤的特效治疗。
英文摘要
NF-?B family transcription factors are critical regulators of
gene transcription. Mutations in the NF-?B pathway are now known to contribute to cellular
transformation and the development of cancer. I have been studying the role of the serine/threonine
kinase Akt in cellular activation and NF-?B induction. Interestingly, Akt is also a proto-oncogene, and is
frequently amplified or activated in cancer. Akt is known to contribute to the activation of numerous
downstream pathways, including NF-?B. I hypothesize that activation of NF-?B is important for the
effects of Akt on T cell activation and transformation. At this point, the overall role of NF-?B in Aktmediated
transcriptional up-regulation is not clear. Also, it is not known precisely how Akt contributes to
NF-?B activation. We have recently made some progress on this latter question, by showing that the
protein CARMA1 is required for Akt-mediated NF-?B induction in T cells. Also, Akt can interact with
CARMA1 and modulate its localization, in addition to increasing the phosphorylation of Bcl10, which is
found in a complex with CARMA1. Based on our preliminary data and the hypothesis stated above,
three specific aims are proposed. (1) To better understand how the interaction between Akt and
CARMA1 affects cellular activation, we will employ a variety of molecular and cell biological approaches
that will reveal in detail how this interaction is regulated. (2) To elucidate the role and regulation of
Bcl10 phosphorylation, we will map sites of inducible phosphorylation within Bel 10 and determine the
role of Akt in their regulation. (3) To determine the global role of NF-?B in Akt-mediated gene regulation
and transformation, we will first use microarray technology and a powerful inhibitor of the NF-?B
pathway to reveal which Akt-inducible genes require NF-?B activity. A similar approach will be
employed to determine the role of NF-?B in Akt-mediated transformation. Completion of these studies
should reveal important information about the cooperation between two important regulators of normal
and neoplastic cell growth - Akt and NF-?B. Relevance: Many studies have shown that dysregulation of
Akt is a common event in cellular transformation. Understanding the role of Akt in normal and
pathological cellular function is complicated by the existence of the multiple downstream pathways that
radiate from Akt. The studies described here will lead to a better understanding of how Akt activates
one of these pathways - the NF-?B family of transcription factors - and the role of this pathway in Aktmediated
gene upregulation and cellular transformation. Such knowledge may eventually lead to more
specific and efficacious treatments for tumors with dysregulated Akt.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bigfoot Spectral Cell Sorter
-
批准号:10419125
-
项目类别:
-
资助金额:$75.49万
-
财政年份:2022
-
负责人:Lawrence P. Kane
-
依托单位:
Regulation of PI3K by PIK3IP1/TrIP
-
批准号:10551871
-
项目类别:
-
资助金额:$32.73万
-
财政年份:2020
-
负责人:Lawrence P. Kane
-
依托单位:
Regulation of PI3K by PIK3IP1/TrIP
-
批准号:10331866
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2020
-
负责人:Lawrence P. Kane
-
依托单位:
Regulation of T cell activation and exhaustion by Tim-3
-
批准号:9981412
-
项目类别:
-
资助金额:$38.84万
-
财政年份:2018
-
负责人:Lawrence P. Kane
-
依托单位:
Regulation of T cell activation and exhaustion by Tim-3
-
批准号:10207229
-
项目类别:
-
资助金额:$7.19万
-
财政年份:2018
-
负责人:Lawrence P. Kane
-
依托单位:
Regulation of T cell activation and exhaustion by Tim-3
-
批准号:10220690
-
项目类别:
-
资助金额:$38.84万
-
财政年份:2018
-
负责人:Lawrence P. Kane
-
依托单位:
Regulation of T cell activation and exhaustion by Tim-3
-
批准号:9762830
-
项目类别:
-
资助金额:$38.84万
-
财政年份:2018
-
负责人:Lawrence P. Kane
-
依托单位:
Regulation of T cell activation and exhaustion by Tim-3
-
批准号:10455832
-
项目类别:
-
资助金额:$7.39万
-
财政年份:2018
-
负责人:Lawrence P. Kane
-
依托单位:
Novel mouse models for studying Tim-3 signaling
-
批准号:9388090
-
项目类别:
-
资助金额:$7.71万
-
财政年份:2017
-
负责人:Lawrence P. Kane
-
依托单位:
Intrinsic Effects of Tim-3 on T cell exhaustion and TCR signaling
-
批准号:8628213
-
项目类别:
-
资助金额:$7.66万
-
财政年份:2014
-
负责人:Lawrence P. Kane
-
依托单位:
Regulation of T Cell Activation and Development by PIK3IP1
-
批准号:8240206
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2012
-
负责人:Lawrence P. Kane
-
依托单位:
Regulation of T Cell Activation and Development by PIK3IP1
-
批准号:8522148
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2012
-
负责人:Lawrence P. Kane
-
依托单位:
Regulation of T Cell Activation and Differentiation by TIM-1
-
批准号:7925979
-
项目类别:
-
资助金额:$15.78万
-
财政年份:2009
-
负责人:Lawrence P. Kane
-
依托单位:
Regulation of NF-kB by the Akt kinase
-
批准号:7678421
-
项目类别:
-
资助金额:$23.77万
-
财政年份:2007
-
负责人:Lawrence P. Kane
-
依托单位:
Regulation of T Cell Activation and Differentiation by TIM-1
-
批准号:7391180
-
项目类别:
-
资助金额:$28.62万
-
财政年份:2007
-
负责人:Lawrence P. Kane
-
依托单位:
Regulation of T Cell Activation and Differentiation by TIM-1
-
批准号:7259749
-
项目类别:
-
资助金额:$20.29万
-
财政年份:2007
-
负责人:Lawrence P. Kane
-
依托单位:
Regulation of NF-kB by the Akt kinase
-
批准号:7904899
-
项目类别:
-
资助金额:$23.53万
-
财政年份:2007
-
负责人:Lawrence P. Kane
-
依托单位:
Regulation of NF-kB by the Akt kinase
-
批准号:7245225
-
项目类别:
-
资助金额:$23.31万
-
财政年份:2007
-
负责人:Lawrence P. Kane
-
依托单位:
Regulation of T Cell Activation and Differentiation by TIM-1
-
批准号:7776828
-
项目类别:
-
资助金额:$28.34万
-
财政年份:2007
-
负责人:Lawrence P. Kane
-
依托单位:
Regulation of NF-kB by the Akt kinase
-
批准号:7487060
-
项目类别:
-
资助金额:$23.39万
-
财政年份:2007
-
负责人:Lawrence P. Kane
-
依托单位:
海外基金